Safety of integrated mass drug administration of azithromycin, albendazole and ivermectin versus standard treatment regimens: a cluster-randomised trial in EthiopiaResearch in context
Summary: Background: Neglected Tropical Disease (NTD) programs require separate and distinct drug regimens for treatment. This has required countries to undertake multiple independent mass drug administration (MDA) programmes, each targeting one or more diseases. The possibility of safely combining...
Main Authors: | Scott McPherson, Getinet Tafese, Temesgen Tafese, Sinknesh Wolde Behaksra, Hiwot Solomon, Birhanu Oljira, Hirpa Miecha, Kaleab A. Debebe, Biruck Kebede, Teshome Gebre, Fikreab Kebede, Fikre Seife, Fentahun Tadesse, Belete Mammo, Abraham Aseffa, Anthony W. Solomon, David C.W. Mabey, Michael Marks, Endalamaw Gadisa |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-05-01
|
Series: | EClinicalMedicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S258953702300161X |
Similar Items
-
Corrigendum to “Safety of integrated mass drug administration of azithromycin, albendazole and ivermectin versus standard treatment regimens: a cluster-randomised trial in Ethiopia”
by: Scott McPherson, et al.
Published: (2023-08-01) -
Perceptions and acceptability of co-administered albendazole, ivermectin and azithromycin mass drug administration, among the health workforce and recipient communities in Ethiopia.
by: Scott McPherson, et al.
Published: (2023-10-01) -
Trachoma then and now: update on mapping and control
by: Anthony W Solomon, et al.
Published: (2018-01-01) -
The Global Trachoma Mapping Project
by: Anthony W Solomon, et al.
Published: (2014-04-01) -
Retracted: Prevalence of active trachoma infection and associated factors post‐war resettled population in raya kobo districts, North East Ethiopia: A community‐based cross‐sectional study in 2022
by: Fassikaw Kebede, et al.
Published: (2023-08-01)